13F Pro

SEC Form 4 reporting owner

Mock James M

Mock James M has filed 38 Form 4 transactions reported between December 5, 2025 and September 10, 2026, as Chief Financial Officer of Moderna, Inc..

Name as filed: Mock James M

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$2.0M
1 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 10, 2026
transaction date

Roles and reported holdings

  • MRNAModerna, Inc.
    Dec 5, 2025 – Sep 10, 2026

    Chief Financial Officer

    Held directly59,375 sh as of Sep 10, 2026 · Form 4

    24 months: $2.0M sold

Transaction history

All 38 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 10, 2026MRNAChief Financial OfficerOpen-market saleCode S · direct15,000$2.0M@ $134.49Form 4
Sep 10, 2026MRNAChief Financial OfficerOption exerciseCode M · direct19,836$614K@ $30.96Form 4
Sep 4, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct5,704$849K@ $148.87Form 4
Sep 4, 2026MRNAChief Financial OfficerOption exerciseCode M · direct11,797—Form 4
Sep 1, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct1,197$168K@ $140.34Form 4
Sep 1, 2026MRNAChief Financial OfficerOption exerciseCode M · direct2,475—Form 4
Aug 28, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct160$23K@ $142.77Form 4
Aug 28, 2026MRNAChief Financial OfficerOption exerciseCode M · direct329—Form 4
Aug 27, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct375$56K@ $149.66Form 4
Aug 27, 2026MRNAChief Financial OfficerOption exerciseCode M · direct774—Form 4
Jul 2, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct703$51K@ $72.50Form 4
Jul 2, 2026MRNAChief Financial OfficerOption exerciseCode M · direct1,452—Form 4
Jun 5, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct5,705$294K@ $51.59Form 4
Jun 5, 2026MRNAChief Financial OfficerOption exerciseCode M · direct11,798—Form 4
Jun 1, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct1,197$56K@ $47.19Form 4
Jun 1, 2026MRNAChief Financial OfficerOption exerciseCode M · direct2,475—Form 4
May 28, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct159$8K@ $47.61Form 4
May 28, 2026MRNAChief Financial OfficerOption exerciseCode M · direct328—Form 4
May 27, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct374$18K@ $47.03Form 4
May 27, 2026MRNAChief Financial OfficerOption exerciseCode M · direct773—Form 4
Apr 2, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct703$35K@ $50.03Form 4
Apr 2, 2026MRNAChief Financial OfficerOption exerciseCode M · direct1,453—Form 4
Mar 5, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct5,704$330K@ $57.80Form 4
Mar 5, 2026MRNAChief Financial OfficerOption exerciseCode M · direct11,797—Form 4
Mar 1, 2026MRNAChief Financial OfficerGrant or awardCode A · direct49,569—Form 4
Mar 1, 2026MRNAChief Financial OfficerGrant or awardCode A · direct37,639—Form 4
Feb 27, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct4,788$248K@ $51.71Form 4
Feb 27, 2026MRNAChief Financial OfficerOption exerciseCode M · direct9,901—Form 4
Feb 27, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct375$19K@ $51.71Form 4
Feb 27, 2026MRNAChief Financial OfficerOption exerciseCode M · direct774—Form 4
Feb 27, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct160$8K@ $51.71Form 4
Feb 27, 2026MRNAChief Financial OfficerOption exerciseCode M · direct329—Form 4
Feb 11, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct1,278$54K@ $41.99Form 4
Feb 11, 2026MRNAChief Financial OfficerGrant or awardCode A · direct2,630—Form 4
Jan 5, 2026MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct780$24K@ $30.86Form 4
Jan 5, 2026MRNAChief Financial OfficerOption exerciseCode M · direct1,452—Form 4
Dec 5, 2025MRNAChief Financial OfficerShares withheld for tax or exercise priceCode F · direct22,817$582K@ $25.49Form 4
Dec 5, 2025MRNAChief Financial OfficerOption exerciseCode M · direct47,190—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.